Last reviewed · How we verify
Varenicline Tartrate Controlled Release — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Varenicline Tartrate Controlled Release (Varenicline Tartrate Controlled Release) — Pfizer.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Varenicline Tartrate Controlled Release TARGET | Varenicline Tartrate Controlled Release | Pfizer | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Varenicline Tartrate Controlled Release CI watch — RSS
- Varenicline Tartrate Controlled Release CI watch — Atom
- Varenicline Tartrate Controlled Release CI watch — JSON
- Varenicline Tartrate Controlled Release alone — RSS
Cite this brief
Drug Landscape (2026). Varenicline Tartrate Controlled Release — Competitive Intelligence Brief. https://druglandscape.com/ci/varenicline-tartrate-controlled-release. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab